The artificial muscle market is expected grow at a CAGR of 11.5% between 2023 to 2032.
The artificial muscle market is expected to reach US$ 6.79 Billion by 2032.
The artificial muscle market was estimated to be US$ 2.29 Billion in 2022.
The artificial muscle market is being driven by several key factors including technological advancements in artificial muscle materials & designs, growing demand for advanced robotics and automation and increasing investments in research and development.
3M Company (United States), Bayer MaterialScience AG (Germany), Eamex Corporation (Japan), Festo AG & Co. KG (Germany), Hstar Technologies Corporation (United States), Koninklijke Philips N.V. (Netherlands), Medtronic plc (Ireland), Musculoskeletal Transplant Foundation (United States), Myomo Inc. (United States), Parker Hannifin Corporation (United States), Permobil AB (Sweden), SRI International (United States), SynTouch LLC (United States), Tecnomatix Technologies Ltd. (Israel), Willow Garage Inc. (United States) among others, are the major players in the artificial muscle market.
Electroactive polymers (EAPs) is the largest segment in the artificial muscle market. Electroactive Polymers have gained significant attention and adoption due to their unique properties and diverse applications.
North America is a prominent region in the global artificial muscle market. The region's strong presence is attributed to factors such as advanced robotics and automation industries, robust research and development activities, and a growing demand for innovative healthcare technologies.
Copyright © 2023 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved